Advances in Pediatric Drug Formulations

Dear Colleagues,

The low availability of appropriate pediatric medications remains a focal point for researchers and pharmaceutical manufacturing companies. Although efforts have been made to stimulate the authorization of pediatric medications, the needs of patients are still far away from being fulfilled. Lately, new solid dosage forms, such as orodispersibles, minitablets, thin films, and 3D-printed dosage forms, have been proposed as alternatives to liquids for different age groups, along with novel devices that ease pediatric drug administration. However, this field requires further research and innovation in terms of the appropriate excipients, product and process development, taste masking, and quality assessment methods. Also, understanding end-user perception and acceptability is needed to guide product formulation and grant treatment adherence. While pediatric drug availability, as well as details on preparation, manipulation, administration practices, and preferences, have long been documented in developed countries, data coming from developing regions are scarce.

We extend an invitation to all stakeholders, including academia, pharmaceutical companies, hospital/community pharmacies, patient associations, and regulatory authorities, to share their results in the aforementioned matters and bridge the knowledge gaps that currently limit the development of pediatric drugs.

Dr. Sonia M. Iurian
Prof. Dr. Ioan Tomuta
Dr. Catalina Bogdan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.